Consistent with these findings, β-catenin downstream target genes ZEB1, SNAIL, and mesenchymal markers (N-cadherin, Vimentin) were reduced with AQB (200nM) treatment in a variety of cancer cell lines. The gene discussed is SNAI1; the disease is cancer.